|
1
|
Trousseau A: Phlegmatia alba dolens. In:
Clinique Medicale de L'Hotel-Dieu de Paris; Vol 3. 2nd edition.
J.-B. Bailliere et fils, Paris, pp654-712, 1865.
|
|
2
|
Metharom P, Falasca M and Berndt MC: The
history of Armand Trousseau and cancer-associated thrombosis.
Cancers (Basel). 11(158)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sack GH Jr, Levin J and Bell WR:
Trousseau's syndrome and other manifestations of chronic
disseminated coagulopathy in patients with neoplasms: Clinical,
pathophysiologic, and therapeutic features. Medicine (Baltimore).
56:1–37. 1977.PubMed/NCBI
|
|
4
|
Ikushima S, Ono R, Fukuda K, Sakayori M,
Awano N and Kondo K: Trousseau's syndrome: Cancer-associated
thrombosis. Jpn J Clin Oncol. 46:204–208. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thompson CM and Rodgers LR: Analysis of
the autopsy records of 157 cases of carcinoma of the pancreas with
particular reference to the incidence of thromboembolism. Am J Med
Sci. 223:469–478. 1952.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Walker AJ, Card TR, West J, Crooks C and
Grainge MJ: Incidence of venous thromboembolism in patients with
cancer-a cohort study using linked United Kingdom databases. Eur J
Cancer. 49:1404–1413. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Khorana AA, Francis CW, Culakova E,
Kuderer NM and Lyman GH: Frequency, risk factors, and trends for
venous thromboembolism among hospitalized cancer patients. Cancer.
110:2339–2346. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khorana AA, Yannicelli D, McCrae KR,
Milentijevic D, Crivera C, Nelson WW and Schein JR: Evaluation of
US prescription patterns: Are treatment guidelines for
cancer-associated venous thromboembolism being followed? Thromb
Res. 145:51–53. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Khorana AA, Francis CW, Culakova E,
Kuderer NM and Lyman GH: Thromboembolism is a leading cause of
death in cancer patients receiving outpatient chemotherapy. J
Thromb Haemost. 5:632–634. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khorana AA: Venous thromboembolism and
prognosis in cancer. Thromb Res. 125:490–493. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sørensen HT, Mellemkjaer L, Olsen JH and
Baron JA: Prognosis of cancers associated with venous
thromboembolism. N Engl J Med. 343:1846–1850. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Khorana AA, Francis CW, Culakova E and
Lyman GH: Risk factors for chemotherapy-associated venous
thromboembolism in a prospective observational study. Cancer.
104:2822–2829. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Prandoni P, Lensing AWA, Piccioli A,
Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins
MH, Noventa F and Girolami A: Recurrent venous thromboembolism and
bleeding complications during anticoagulant treatment in patients
with cancer and venous thrombosis. Blood. 100:3484–3488.
2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cancer Information Service, National
Cancer Center, Vital Statistics of Japan, Ministry of Health,
Labour and Welfare: Cancer statistics in Japan. https://ganjoho.jp/reg_stat/statistics/data/dl/en.html.
Accessed April 1, 2023.
|
|
16
|
Shimoyama R, Imamura Y, Uryu K, Mase T,
Fujimura Y, Hayashi M, Ohtaki M, Ohtani K, Shinozaki N and Minami
H: Real-world treatment outcomes among patients with metastatic
pancreatic cancer in Japan: The Tokushukai Real-world Data Project.
Mol Clin Oncol. 19(98)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ohashi Y, Ikeda M, Kunitoh H, Sasako M,
Okusaka T, Mukai H, Fujiwara K, Nakamura M, Oba MS, Kimura T, et
al: Venous thromboembolism in cancer patients: Report of baseline
data from the multicentre, prospective Cancer-VTE Registry. Jpn J
Clin Oncol. 50:1246–1253. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shimoyama R, Imamura Y, Uryu K, Mase T,
Fujimura Y, Hayashi M, Ohtaki M, Ohtani K, Shinozaki N and Minami
H: Real-world outcomes of systemic therapy in Japanese patients
with cancer (Tokushkai REAl-world Data project: TREAD): Study
protocol for a nationwide cohort study. Healthcare (Basel).
10(2146)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Eba J and Nakamura K: Overview of the
ethical guidelines for medical and biological research involving
human subjects in Japan. Jpn J Clin Oncol. 52:539–544.
2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
National Cancer Registry (Ministry of
Health, Labour and Welfare), tabulated by Cancer Information
Service, National Cancer Center, Japan. https://ganjoho.jp/med_pro/cancer_control/can_reg/hospital/index.html.
Accessed April 1, 2023.
|
|
21
|
Alotaibi GS, Wu C, Senthilselvan A and
McMurtry MS: The validity of ICD codes coupled with imaging
procedure codes for identifying acute venous thromboembolism using
administrative data. Vasc Med. 20:364–368. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bosco E, Hsueh L, McConeghy KW,
Gravenstein S and Saade E: Major adverse cardiovascular event
definitions used in observational analysis of administrative
databases: A systematic review. BMC Med Res Methodol.
21(241)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Winell K, Arffman M, Pietilä A and Salomaa
V: Regional differences in the incidence of diabetic cardiovascular
events reflect the quality of care. Scand Cardiovasc J. 52:232–237.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Reinecke H, Unrath M, Freisinger E,
Bunzemeier H, Meyborg M, Lüders F, Gebauer K, Roeder N, Berger K
and Malyar NM: Peripheral arterial disease and critical limb
ischaemia: Still poor outcomes and lack of guideline adherence. Eur
Heart J. 36:932–938. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Al-Ani F, Shariff S, Siqueira L, Seyam A
and Lazo-Langner A: Identifying venous thromboembolism and major
bleeding in emergency room discharges using administrative data.
Thromb Res. 136:1195–1198. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Quan H, Sundararajan V, Halfon P, Fong A,
Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE and Ghali WA:
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10
administrative data. Med Care. 43:1130–1139. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Khorana AA, Kuderer NM, Culakova E, Lyman
GH and Francis CW: Development and validation of a predictive model
for chemotherapy-associated thrombosis. Blood. 111:4902–4907.
2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ay C, Dunkler D, Marosi C, Chiriac AL,
Vormittag R, Simanek R, Quehenberger P, Zielinski C and Pabinger I:
Prediction of venous thromboembolism in cancer patients. Blood.
116:5377–5382. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Suzuki T, Hori R, Takeuchi K, Yamamura R,
Katoh H, Noji Y, Yamaguchi M and Fujino S: Venous thromboembolism
in Japanese patients with pancreatic cancer. Clin Appl Thromb
Hemost. 27(10760296211051766)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mandalà M, Reni M, Cascinu S, Barni S,
Floriani I, Cereda S, Berardi R, Mosconi S, Torri V and Labianca R:
Venous thromboembolism predicts poor prognosis in irresectable
pancreatic cancer patients. Ann Oncol. 18:1660–1665.
2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Barrau M, Maoui K, Le Roy B, Roblin X,
Mismetti P, Phelip JM and Williet N: Early venous thromboembolism
is a strong prognostic factor in patients with advanced pancreatic
ductal adenocarcinoma. J Cancer Res Clin Oncol. 147:3447–3454.
2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ohashi Y, Ikeda M, Kunitoh H, Sasako M,
Okusaka T, Mukai H, Fujiwara K, Nakamura M, Oba MS, Kimura T, et
al: One-year incidence of venous thromboembolism, bleeding, and
death in patients with solid tumors newly initiating cancer
treatment: Results from the Cancer-VTE Registry. Thromb Res.
213:203–213. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Navi BB, Reiner AS, Kamel H, Iadecola C,
Okin PM, Elkind MSV, Panageas KS and DeAngelis LM: Risk of arterial
thromboembolism in patients with cancer. J Am Coll Cardiol.
70:926–938. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tuzovic M, Herrmann J, Iliescu C,
Marmagkiolis K, Ziaeian B and Yang EH: Arterial thrombosis in
patients with cancer. Curr Treat Options Cardiovasc Med.
20(40)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hung YS, Chen JS, Chen YY, Lu CH, Chang PH
and Chou WC: Incidence, risk factors, and outcomes of arterial
thromboembolism in patients with pancreatic cancer following
palliative chemotherapy. Cancers (Basel). 10(432)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Riedl JM, Schwarzenbacher E, Moik F,
Horvath L, Gantschnigg A, Renneberg F, Posch F, Barth DA, Stotz M,
Pichler M, et al: Patterns of thromboembolism in patients with
advanced pancreatic cancer undergoing first-line chemotherapy with
FOLFIRINOX or gemcitabine/nab-paclitaxel. Thromb Haemost.
122:633–645. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Aonuma AO, Nakamura M, Sakamaki K, Murai
T, Matsuda C, Itaya K, Sone T, Yagisawa M, Koike Y, Endo A, et al:
Incidence of cancer-associated thromboembolism in Japanese gastric
and colorectal cancer patients receiving chemotherapy: A
single-institutional retrospective cohort analysis (Sapporo CAT
study). BMJ Open. 9(e028563)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Schattner A, Klepfish A, Huszar M and
Shani A: Two patients with arterial thromboembolism among 311
patients with adenocarcinoma of the pancreas. Am J Med Sci.
324:335–338. 2002.PubMed/NCBI View Article : Google Scholar
|
|
39
|
El Sakka K, Gambhir RP, Halawa M, Chong P
and Rashid H: Association of malignant disease with critical leg
ischaemia. Br J Surg. 92:1498–1501. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Okushi Y, Kusunose K, Okayama Y, Zheng R,
Nakai M, Sumita Y, Ise T, Tobiume T, Yamaguchi K, Yagi S, et al:
Acute hospital mortality of venous thromboembolism in patients with
cancer from registry data. J Am Heart Assoc.
10(e019373)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ha J, Lee MJ, Kim SJ, Park BY, Park H, Cho
S, Chung JW, Seo WK, Kim GM, Bang OY and Chung CS: Prevalence and
impact of venous and arterial thromboembolism in patients with
embolic stroke of undetermined source with or without active
cancer. J Am Heart Assoc. 8(e013215)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ageno W, Becattini C, Brighton T, Selby R
and Kamphuisen PW: Cardiovascular risk factors and venous
thromboembolism: A meta-analysis. Circulation. 117:93–102.
2008.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Verso M, Agnelli G, Barni S, Gasparini G
and LaBianca R: A modified Khorana risk assessment score for venous
thromboembolism in cancer patients receiving chemotherapy: The
Protecht score. Intern Emerg Med. 7:291–292. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
van Es N, Di Nisio M, Cesarman G, Kleinjan
A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, et
al: Comparison of risk prediction scores for venous thromboembolism
in cancer patients: A prospective cohort study. Haematologica.
102:1494–1501. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sohal DP, Shrotriya S, Glass KT, Pelley
RJ, McNamara MJ, Estfan B, Shapiro M, Wey J, Chalikonda S,
Morris-Stiff G, et al: Predicting early mortality in resectable
pancreatic adenocarcinoma: A cohort study. Cancer. 121:1779–1784.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Aoyagi T, Terracina KP, Raza A, Matsubara
H and Takabe K: Cancer cachexia, mechanism and treatment. World J
Gastrointest Oncol. 7:17–29. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Poulia KA, Sarantis P, Antoniadou D,
Koustas E, Papadimitropoulou A, Papavassiliou AG and Karamouzis MV:
Pancreatic cancer and cachexia-metabolic mechanisms and novel
insights. Nutrients. 12(1543)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Khorana AA: Cancer and thrombosis:
Implications of published guidelines for clinical practice. Ann
Oncol. 20:1619–1630. 2009.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mandalà M, Falanga A and Roila F: ESMO
Guidelines Working Group. Management of venous thromboembolism
(VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann
Oncol 22 Suppl. 6:vi85–vi92. 2011.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ramcharitar RK, Man L, Khaja MS, Barnett
ME and Sharma A: A review of the past, present and future of
cancer-associated thrombosis management. Heart Int. 16:117–123.
2022.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Farge D, Frere C, Connors JM, Khorana AA,
Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, et al:
2022 international clinical practice guidelines for the treatment
and prophylaxis of venous thromboembolism in patients with cancer,
including patients with COVID-19. Lancet Oncol. 23:e334–e347.
2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lyon AR, López-Fernández T, Couch LS,
Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D,
Cordoba R, Cosyns B, et al: 2022 ESC Guidelines on cardio-oncology
developed in collaboration with the European Hematology Association
(EHA), the European Society for Therapeutic Radiology and Oncology
(ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur
Heart. 43:4229–4361. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Key NS, Khorana AA, Kuderer NM, Bohlke K,
Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Gates LE, et
al: Venous thromboembolism prophylaxis and treatment in patients
with cancer: ASCO guideline update. J Clin Oncol. 41:3063–3071.
2023.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Falanga A, Ay C, Di Nisio M, Gerotziafas
G, Jara-Palomares L, Langer F, Lecumberri R, Mandala M, Maraveyas
A, Pabinger I, et al: Venous thromboembolism in cancer patients:
ESMO clinical practice guideline. Ann Oncol. 34:452–467.
2023.PubMed/NCBI View Article : Google Scholar
|
